BA
BNTX icon

Bridgewater Associates’s BioNTech BNTX Stock Holding History

Bridgewater Associates’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,927
Closed -$469K – 1022
2025
Q4 		$469K Buy
+4,927
New +$496K ﹤0.01% 979
2025
Q2 		– Sell
-14,319
Closed -$1.3M – 606
2025
Q1 		$1.3M Sell
14,319
-5,958
-29% -$667K 0.01% 499
2024
Q4 		$2.31M Buy
20,277
+14,604
+257% +$1.67M 0.01% 429
2024
Q3 		$674K Buy
+5,673
New +$522K ﹤0.01% 658
2024
Q1 		– Sell
-4,083
Closed -$431K – 702
2023
Q4 		$431K Buy
+4,083
New +$411K ﹤0.01% 710
2022
Q3 		– Sell
-12,156
Closed -$1.81M – 888
2022
Q2 		$1.81M Buy
+12,156
New +$1.86M 0.01% 699

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bridgewater Associates's BNTX Position: Q1 2026 in Review

Bridgewater Associates sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 4,927 shares — an estimated $469K sold.

Bridgewater Associates first reported a position in BNTX in Q2 2022 and held it in 6 quarters. The position peaked at $2.31M in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Bridgewater Associates reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • Bridgewater Associates sold 4,927 BioNTech shares in Q1 2026, an estimated $469K.
  • Bridgewater Associates first reported a position in BioNTech in Q2 2022 and held it in 6 quarters.
  • Bridgewater Associates's BioNTech position peaked at $2.31M in Q4 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.